AIRE by Briya Brings Conversational AI to Health Data Research

In a Medika Life exclusive Briya’s announcement at HLTH Europe marks an important shift in how artificial intelligence may support medical research and healthcare decision-making. By opening no-cost access to AIRE, its conversational AI research platform, Briya is attempting to reduce the technical barriers that often prevent researchers from quickly exploring public health data, testing hypotheses, validating endpoints, and moving from observation to evidence.

Read the full article here: MedikaLife

Instead of relying on coding-heavy workflows or fragmented data systems, researchers can ask questions in natural language, review analytical pathways, and engage with public health information in a more accessible, transparent environment. The company’s emphasis on reproducibility, epidemiological rigor, privacy, and auditable analysis is especially important as healthcare organizations evaluate the responsible use of AI.

This subject connects directly to pharmacist consultative care because pharmacists increasingly serve as frontline interpreters of medication data, chronic disease trends, adherence challenges, and patient outcomes.

"Generic models weren’t built for clinical complexity. Ours are. We train AI on rich, real-world medical data, ensuring accuracy, context, and relevance for you."

If platforms like AIRE accelerate research around treatment pathways, cardiometabolic disease, diabetes, specialty medications, and population health patterns, pharmacy teams could gain faster access to evidence that informs patient counseling and care planning. Pharmacists may be impacted by more data-driven consultative roles, especially in medication therapy management, chronic disease coaching, pharmacogenomics, adherence interventions, and collaborative care models.

Community and specialty pharmacies could also use emerging research insights to better identify gaps in therapy, support prescribers, and document improved outcomes. The larger implication is that AI-enabled research may elevate pharmacy from a dispensing-centered model toward a consultative, evidence-informed care model where pharmacists help translate scientific discovery into practical patient support.